It's probably not a big deal, but there are a few things to sign yet. Most of my analysis work is related to developing peptide-drug conjugates, so this will be a departure. The general idea is to improve on a specific QC process for acquired field data, adjusting correction factors on the basis of observed phenomena. The results should boil down to improved efficiency in some regard, but I'm not sure about the specifics yet.